A Comparison between Single and Double-Dose Intravenous Ketamine Administration in Bipolar Mood Disorder: A Double-Blind Controlled Clinical Trial

Objective: As glutamatergic system dysfunction is involved in bipolar depression pathophysiology, the glutamate receptor modulators such as Ketamine have been applied as complementary medication for mood stabilizers. While the treatment is currently just the intravenous injection of a single dose, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Talaei, Ali, Farid Hoseini, Farhad, Mahdavi, Meisam, Salehi, Maryam, Karimani, Asieh, Afzaljavan, Fahimeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Psychiatry & Psychology Research Center, Tehran University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593997/
https://www.ncbi.nlm.nih.gov/pubmed/37881420
http://dx.doi.org/10.18502/ijps.v18i4.13627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593997/
https://www.ncbi.nlm.nih.gov/pubmed/37881420
http://dx.doi.org/10.18502/ijps.v18i4.13627

Ejemplares similares